The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Larazotide Acetate for Persistent Symptoms of Celiac Disease Despite a Gluten-Free Diet: A Randomized Controlled Trial
Open accessAbstract
Background & Aims Celiac disease (CeD) is a prevalent autoimmune condition. Recurrent signs and symptoms are common despite treatment with a gluten free diet (GFD), yet no approved or proven non-dietary treatment is available. Methods In this multicenter randomized, double-blind, placebo-controlled study, we assessed larazotide acetate 0.5, 1, or 2 mg three times daily to relieve ongoing symptoms in 342 adults with CeD who had been on a GFD for ≥12 months and maintained their current GFD during the study. The study included a 4-week placebo run-in, 12-week treatment, and 4-week placebo run-out phase. The primary endpoint was the difference in average on-treatment Celiac Disease Gastrointestinal Symptom Rating Scale score (CeD-GSRS). Results The primary endpoint was met at the 0.5 mg dose of larazotide acetate with fewer symptoms compared with placebo by Modified Intention to Treat (n=340) (ANCOVA p=0.022, MMRM p=0.005). The 0.5mg dose showed effect on exploratory endpoints including, 26% decrease in Celiac Disease Patient Reported Outcome Symptomatic Days (p=0.017); 31% increase in Improved Symptom Days (p=0.034); ≥50% reduction from baseline of weekly average Abdominal Pain Score for ≥6 out of 12 weeks of treatment (p=0.022); and a decrease in Non-GI symptoms of headache and tiredness (p=0.010). The 1 and 2 mg doses were no different than placebo for any endpoint. Safety was comparable to placebo. Conclusions Larazotide acetate 0.5 mg reduced signs and symptoms in CeD patients on a GFD better than a GFD alone. While results were mixed, this study represents the first successful trial of a novel therapeutic agent targeting Tight Junction regulation in patients with CeD who are symptomatic despite a GFD. Clinicaltrials.gov, NCT01396213
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holmes, G. K. T., & Cooke, W. T. (1984) · Cited by 2,638
Green, P. H. R., & Jones, R. (2006) · Cited by 2,453
Self-citationThe Oslo definitions for coeliac disease and related terms
Ludvigsson, J. F., Leffler, D. A., Bai, J. C., Biagi, F., Fasano, A., Green, P. H. R., Hadjivassiliou, M., Kaukinen, K., Kelly, C. P., Leonard, J. N., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301346 · Cited by 1,721
Self-citationGreen, P. H. R., & Cellier, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071600 · Cited by 1,625
Self-citationSvedlund, J., Sj�din, I., & Dotevall, G. (1988) · Digestive Diseases and Sciences · doi:10.1007/bf01535722 · Cited by 1,468
Ludvigsson, J. F., Bai, J. C., Biagi, F., Card, T. R., Ciacci, C., Ciclitira, P. J., Green, P. H. R., Hadjivassiliou, M., Holdoway, A., van Heel, D. A., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306578 · Cited by 1,116
Self-citationAlterations in intestinal permeability
Arrieta, M. C., Bistritz, L., & Meddings, J. B. (2006) · Gut · doi:10.1136/gut.2005.085373 · Cited by 634
Celiac Disease: From Pathogenesis to Novel Therapies
Schuppan, D., Junker, Y., & Barisani, D. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.008 · Cited by 606
Catassi, C., Fabiani, E., Iacono, G., D'Agate, C., Francavilla, R., Biagi, F., Volta, U., Accomando, S., Picarelli, A., De Vitis, I., et al. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.1.160 · Cited by 585
Molecular Basis of Epithelial Barrier Regulation
Turner, J. R. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.060681 · Cited by 541
Lammers, K. M., Lu, R., Brownley, J., Lu, B., Gerard, C., Thomas, K., Rallabhandi, P., Shea-Donohue, T., Tamiz, A., Alkan, S., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.023 · Cited by 540
Mucosal Recovery and Mortality in Adults With Celiac Disease After Treatment With a Gluten-Free Diet
Rubio-Tapia, A., Rahim, M. W., See, J. A., Lahr, B. D., Wu, T.-T., & Murray, J. A. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2010.10 · Cited by 403
Self-citationKulich, K. R., Madisch, A., Pacini, F., Piqué, J. M., Regula, J., Van Rensburg, C. J., Újszászy, L., Carlsson, J., Halling, K., & Wiklund, I. K. (2008) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-6-12 · Cited by 396
Two randomized trials of linaclotide for chronic constipation
Lembo, A. J., Schneier, H. A., Shiff, S. J., Kurtz, C. B., MacDougall, J. E., Jia, X. D., Shao, J. Z., Lavins, B. J., Currie, M. G., Fitch, D. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010863 · Cited by 373 · cited 1×
“This level of improvement is similar to what is regarded as clinically meaningful in other conditions with episodic symptoms.(27-29)”
ResultEtiologies and Predictors of Diagnosis in Nonresponsive Celiac Disease
Leffler, D. A., Dennis, M., Hyett, B., Kelly, E., Schuppan, D., & Kelly, C. P. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.12.006 · Cited by 339
Self-citationInterpreting patient-reported outcome results: US FDA guidance and emerging methods
McLeod, L. D., Coon, C. D., Martin, S. A., Fehnel, S. E., & Hays, R. D. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.12 · Cited by 320
Aurora, S. K., Winner, P., Freeman, M. C., Spierings, E. L., Heiring, J. O., DeGryse, R. E., VanDenburgh, A. M., Nolan, M. E., & Turkel, C. C. (2011) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01990.x · Cited by 295
PATERSON, B. M., LAMMERS, K. M., ARRIETA, M. C., FASANO, A., & MEDDINGS, J. B. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03413.x · Cited by 279
Leffler, D., Schuppan, D., Pallav, K., Najarian, R., Goldsmith, J. D., Hansen, J., Kabbani, T., Dennis, M., & Kelly, C. P. (2013) · Gut · doi:10.1136/gutjnl-2012-302196 · Cited by 237
Self-citationShah, S., Akbari, M., Vanga, R., Kelly, C. P., Hansen, J., Theethira, T., Tariq, S., Dennis, M., & Leffler, D. A. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.29 · Cited by 233
Self-citationGluten-free diet and quality of life in patients with screen-detected celiac disease.
Mustalahti, K., Lohiniemi, S., Collin, P., Vuolteenaho, N., Laippala, P. J., & Mäki, M. (2002) · PubMed · Cited by 210
Kelly, C. P., Green, P. H. R., Murray, J. A., DiMarino, A., Colatrella, A., Leffler, D. A., Alexander, T., Arsenescu, R., Leon, F., Jiang, J. G., et al. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12147 · Cited by 202
Self-citationLeffler, D. A., Kelly, C. P., Abdallah, H. Z., Colatrella, A. M., Harris, L. A., Leon, F., Arterburn, L. A., Paterson, B. M., Lan, Z. H., & Murray, J. A. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.211 · Cited by 187
Self-citationBenefits of a Gluten-Free Diet for Asymptomatic Patients With Serologic Markers of Celiac Disease
Kurppa, K., Paavola, A., Collin, P., Sievänen, H., Laurila, K., Huhtala, H., Saavalainen, P., Mäki, M., & Kaukinen, K. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.05.003 · Cited by 173
Barratt, S. M., Leeds, J. S., & Sanders, D. S. (2011) · PubMed · Cited by 159
Black, K. E., Murray, J. A., & David, C. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5595 · Cited by 153
Self-citationLarazotide acetate regulates epithelial tight junctions in vitro and in vivo
Gopalakrishnan, S., Durai, M., Kitchens, K. M., Tamiz, A. P., Somerville, R. P. T., Ginski, M. J., Paterson, B. M., Murray, J. A., Verdu, E. F., Alkan, Ş. Ş., et al. (2012) · Peptides · doi:10.1016/j.peptides.2012.02.015 · Cited by 125
Self-citationIntentional and inadvertent non-adherence in adult coeliac disease. A cross-sectional survey
Hall, N. J., Rubin, G. P., & Charnock, A. (2013) · Appetite · doi:10.1016/j.appet.2013.04.016 · Cited by 123
Mucosal healing and mortality in coeliac disease
Lebwohl, B., Granath, F., Ekbom, A., Montgomery, S., Murray, J. A., Rubio‐Tapia, A., Green, P. H. R., & Ludvigsson, J. F. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12164 · Cited by 121
Self-citationLohiniemi, M. M. S. (2000) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655200750023002 · Cited by 98
Are patients with coeliac disease seeking alternative therapies to a gluten-free diet?
Aziz, I., Evans, K., Papageorgiou, V., & Sanders, D. S. (2011) · PubMed · Cited by 76
Larazotide acetate promotes tight junction assembly in epithelial cells
Gopalakrishnan, S., Tripathi, A. K., Tamiz, A. P., Alkan, Ş. Ş., & Pandey, N. B. (2012) · Peptides · doi:10.1016/j.peptides.2012.02.016 · Cited by 75
Mooney, P. D., Hadjivassiliou, M., & Sanders, D. S. (2014) · BMJ · doi:10.1136/bmj.g1561 · Cited by 63
MacDougall, J., Johnston, J. M., Lavins, B. J., Nelson, L. M., Williams, V. S. L., Carson, R. T., Shiff, S. J., Shi, K., Kurtz, C. B., Baird, M. J., et al. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12089 · Cited by 26
Verma, S., & Giaffer, M. H. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1015823320831 · Cited by 18
Management of Celiac Disease: Beyond the Gluten-Free Diet
Crowe, S. E. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.027 · Cited by 8
Cited by
Celiac disease: a comprehensive current review
Caio, G., Volta, U., Sapone, A., Leffler, D. A., De Giorgio, R., Catassi, C., & Fasano, A. (2019) · BMC Medicine · doi:10.1186/s12916-019-1380-z · Cited by 1,105
Self-citationLebwohl, B., Sanders, D. S., & Green, P. H. R. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31796-8 · Cited by 1,065
Self-citationAkdis, C. A. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00538-7 · Cited by 981
Sturgeon, C., & Fasano, A. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1251384 · Cited by 497
Fasano, A. (2020) · F1000Research · doi:10.12688/f1000research.20510.1 · Cited by 481
Metadata
- Authors
- Leffler, D. A., Kelly, C. P., Green, P. H. R., Fedorak, R. N., DiMarino, A., Perrow, W., Rasmussen, H., Wang, C., Bercik, P., Bachir, N. M., & Murray, J. A.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 148
- Issue
- 7
- Pages
- 1311-1319.e6
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2162876267
- Cited by
- 263
- References
- 36
- FWCI
- 20.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.